Morphine (Chlorhydrate) Lavoisier (Morphine Hydrochloride)

Morphine, the active ingredient in Morphine (Chlorhydrate) Lavoisier, is an opioid analgesic presented as a sterile solution for epidural and intracerebroventricular use. It is employed to treat severe acute, postoperative and cancer‑related pain in adult patients.

GNH USA supplies Morphine (Chlorhydrate) Lavoisier as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres and pharmacies worldwide.

Morphine acts on the central opioid pathway to provide potent analgesia for intense pain conditions.

- Severe acute pain: delivers rapid, strong relief for sudden, high‑intensity pain episodes. - Postoperative pain: helps control pain after surgical procedures, facilitating recovery. - Cancer pain: provides sustained analgesia for malignant disease‑related discomfort.

Morphine may cause a range of adverse reactions that vary in frequency and severity.

Common Side Effects: - Nausea: feeling of sickness often accompanied by vomiting. - Constipation: reduced bowel motility leading to hard stools. - Drowsiness: increased sleepiness or reduced alertness.

Serious or Rare Side Effects: - Respiratory depression: markedly slowed breathing that can be life‑threatening. - Severe hypotension: sudden drop in blood pressure causing dizziness or fainting. - Anaphylactic reaction: rare allergic response with rash, swelling, and airway compromise.

When using morphine, careful clinical assessment and monitoring are essential to minimise risk.

- Pain assessment: evaluate severity and type before initiating therapy. - Respiratory monitoring: observe breathing rate and oxygen saturation regularly. - Opioid tolerance: consider prior opioid exposure when selecting dose. - Concomitant CNS depressants: avoid or adjust dose when used with other sedatives. - Renal/hepatic impairment: adjust dosing in patients with organ dysfunction. - Store at controlled room temperature: keep in original container, protect from moisture and light.

Morphine interacts with several drug classes; awareness helps prevent harmful effects.

Major Interactions (Avoid): - Benzodiazepines: additive central nervous system depression may cause severe sedation. - MAO inhibitors: risk of hypertensive crisis or serotonin syndrome when combined. - Respiratory depressants (e.g., barbiturates): can produce profound respiratory depression.

Moderate Interactions (Monitor Closely): - CYP3A4 inhibitors (e.g., erythromycin): may increase morphine plasma concentrations. - Diuretics: can enhance hypotensive effects, requiring blood pressure monitoring.